Indian Poverty and Cardiovascular Disease††Conflict of interest: Dr. Alpert has been a consultant for Sanofi-Aventis, Paris France; Novartis International AG, Basel, Switzerland; Exeter CME, Inc., New York, New York; and King Pharmaceuticals, Inc., Bristol, Tennessee
| Autor: | Joseph S. Alpert, Radhakrishnan Ramaraj |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Gerontology
medicine.medical_specialty education.field_of_study Poverty business.industry Population Developing country Disease medicine.disease Coronary artery disease Infectious disease (medical specialty) Internal medicine Environmental health Epidemiology medicine Life expectancy Cardiology Cardiology and Cardiovascular Medicine education business |
| Zdroj: | The American Journal of Cardiology. 102:102-106 |
| ISSN: | 0002-9149 |
| DOI: | 10.1016/j.amjcard.2008.02.104 |
| Popis: | Cardiovascular disease is among the world's leading causes of death, and nearly 80% of deaths occur in developing countries. Cardiovascular disease is becoming a major health problem in India, where life expectancy has increased with decreases in infectious disease and childhood mortality. It is well established that this population experiences coronary artery disease at a younger age than other populations. With infectious diseases still endemic, noncommunicable diseases are a lower priority for the governments of developing countries. There is a clear progression to degenerative and lifestyle-related diseases such as cardiovascular disease as a result of current social and economic change. The lack of a public response to the increasing risk for cardiovascular disease thus far is due mostly to a perception among policy makers and the public that cardiovascular disease is largely a problem of the urban rich. In conclusion, this review addresses the imminent threats and ways to tackle the epidemic in India. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect